Overview

Evaluate the Clinical Usefulness of [F-18]Florastamin PET/CT Imaging Diagnosis Compared to MRI Diagnosis

Status:
Recruiting
Trial end date:
2022-05-31
Target enrollment:
Participant gender:
Summary
Only in subjects who satisfy the inclusion/exclusion criteria, a single dose of [F-18]Florastamin at 10 ± 1 mCi is IV administered at Visit 2, and [F-18]Florastamin PET/CT images are obtained from the head to thigh after 110 ± 10 minutes.
Phase:
Phase 3
Details
Lead Sponsor:
FutureChem